van Willigen G, Hers I, Gorter G, Akkerman J W
Department of Haematology, University Hospital Utrecht, The Netherlands.
Biochem J. 1996 Mar 15;314 ( Pt 3)(Pt 3):769-79.
The exposure of ligand-binding sites for adhesive proteins on platelet integrin alpha IIB/beta 3 (glycoprotein IIB/IIIA) by platelet-activating (PAF) is transient, whereas sites exposed by alpha-thrombin remain accessible. The same difference is seen in the phosphorylation of the beta 3 subunit. Inhibition of protein kinases (1 microM staurosporine) and protein kinase C (10 microM bisindolylmaleimide) closes binding sites exposed by both agonists and induces dephosphorylation of beta 3. Inhibition of Tyr-kinases (20 microM Herbimycin A) has only a slight effect. Inhibition of Ser/Thr-phosphatases (1 microM okadaic acid, 30 s preincubation) changes the transient exposure and beta phosphorylation by PAF into the 'permanent' patterns induced by alpha-thrombin. Inhibition of Tyr-phosphatases (100 microM vanadate) has little effect. Preincubation with okadaic acid makes exposed binding sites and phosphorylated beta 3 insensitive to staurosporine, resulting in exposed alpha IIB/beta 3 independent of concurrent phosphorylation/dephosphorylation. The stoichiometry of beta 3 phosphorylation by alpha-thrombin is 0.80+/-0.10. Thus, one of the mechanisms that regulates exposure and closure of ligand-binding sites on the alpha IIb/beta 3 is phosphorylation/dephosphorylation of a Ser/Thr-residue in the beta 3 subunit.
血小板激活因子(PAF)使血小板整合素αIIb/β3(糖蛋白IIb/IIIa)上黏附蛋白的配体结合位点暴露是短暂的,而α-凝血酶暴露的位点则保持可及状态。β3亚基的磷酸化也存在同样的差异。蛋白激酶抑制剂(1μM星形孢菌素)和蛋白激酶C抑制剂(10μM双吲哚马来酰胺)会封闭两种激动剂暴露的结合位点,并诱导β3去磷酸化。酪氨酸激酶抑制剂(20μM赫曲霉素A)只有轻微作用。丝氨酸/苏氨酸磷酸酶抑制剂(1μM冈田酸,预孵育30秒)会将PAF诱导的短暂暴露和β磷酸化转变为由α-凝血酶诱导的“永久”模式。酪氨酸磷酸酶抑制剂(100μM钒酸盐)作用不大。用冈田酸预孵育会使暴露的结合位点和磷酸化的β3对星形孢菌素不敏感,导致αIIb/β3暴露,且与同时发生的磷酸化/去磷酸化无关。α-凝血酶使β3磷酸化的化学计量比为0.80±0.10。因此,调节αIIb/β3上配体结合位点暴露和封闭的机制之一是β3亚基中丝氨酸/苏氨酸残基的磷酸化/去磷酸化。